National Cancer Institute

National Cancer Institute

National Cancer Institute

Date Founded




Type of Company


Employees (Worldwide)

10K - 1M


Investment Services & Portfolio Management
IT Consulting & Services
Hospitals & Patient Services
Social Interest
Medical Support Services
Computer Software

Company Description

The National Cancer Institute (NCI) is part of the National Institutes of Health (NIH), which is one of 11 agencies that compose the Department of Health and Human Services (HHS). The NCI, established under the National Cancer Institute Act of 1937, is the Federal Government's principal agency for cancer research and training. The National Cancer Act of 1971 broadened the scope and responsibilities of the NCI and created the National Cancer Program. Over the years, legislative amendments have maintained the NCI authorities and responsibilities and added new information dissemination mandates as well as a requirement to assess the incorporation of state-of-the-art cancer treatments into clinical practice.

Contact Data
Trying to get in touch with decision makers at National Cancer Institute? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief-Laboratory of Cell Biology, Center for Cancer Research

Head-Drug Mechanism Labs

Head of Research

Head, Chemical Glycobiology Section, Chemical Biology Laboratory, Center for Cancer Research

Director-Center for Biomedical Informatics

Director-Cancer Research Center

Director, Center for Global Health

Principal Investigator, National Cooperative Drug Discovery Group Grant

Director of Nanotechnology for Cancer Programs

Board of Directors

Chairman & Group Chief Executive Officer at Palm Hills Development Co.

Chief Medical Advisor at Wanderly

Chief Network Officer at The Institute for Cancer Research

Vice President at Maritima Mexicana SA de CV

Director at National Cancer Institute

Director at National Cancer Institute

Director at National Cancer Institute

Distinguished Alumni
James Mulé is now Executive Vice President at Translational Research In Oncology
Paths to National Cancer Institute
Potential Connections via
Relationship Science
National Cancer Institute
Advisors & Consultants

Chairman & Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine at University of Texas - MD Anderson Cancer Center


Professor at Georgia Institute of Technology - School of Public Policy


Provost & Dean of the Faculty Emeritus at Columbia University - Barnard College

Non-Profit Donations & Grants
Non-Profit Donations & Grants Received
Details Hidden

Adheren Biologics, Inc. operates as a biotechnology company focusing on cancer immunotherapy. The company was founded by Sonny Hsiao in June 2010 and is headquartered in Emeryville, CA.

Details Hidden

AxoTect, Inc. develops treatments for neurological disorders. It is a small-molecule drugs for the treatment of pain associated with Chemotherapy induced peripheral neuropathy (CPIN). The company was founded in 2005 and is headquartered in Atlanta, GA.

Details Hidden

YouV Labs develops wearable technology to accurately measure solar ultraviolet (UV) radiation. The firm connects to the smartphone via Bluetooth, enabling lupus patients to discover and manage its personal tolerance to UV exposure directly on their smartphones. The company was founded by Emmanuel Dumontin and Shayak Banerjee in 2014 and is headquartered in New York, NY.

Medidata Solutions, Inc. Internet Software & Services | New York, NY

Welcome to Medidata Solutions. We recognize that our customers' life science research fosters the critically important goals of bringing life-saving and life-enhancing treatments to the public, and we are proud to support this work. Medidata is committed to providing clinical research organizations with the most advanced tools for planning and managing their clinical trials. Our mission is to put innovative technology and insightful data into researchers' hands to help bring treatments to market as safely, efficiently and effectively as possible. The Medidata team has looked at all steps of the clinical trial process—spanning operational and clinical activities—and created solutions for companies of all sizes that use cutting-edge technology, process change management and implementation planning, and robust databases and analytics to take risk, time and resources out of the trial process. By focusing on critical decision-points in clinical research, we are working to develop solutions that provide all members of the research team with novel analytic tools and information technology to maximize their clinical investments

Dyadic International, Inc. Industrial Machinery & Manufacturing | Jupiter, Florida

Dyadic International, Inc. engages in developing a gene expression platform for producing commercial quantities of industrial enzymes and other proteins. It focuses on further improving and applying its proprietary C1 technology, which is used in the discovery, development, and manufacture of biologic medicines and vaccines. The company was founded by Mark A. Emalfarb in 1979 and is headquartered in Jupiter, FL.

Brooks Automation, Inc. Computer Software | Chemsford, MA

Brooks is a leading worldwide provider of automation, vacuum, and instrumentation solutions for multiple markets including semiconductor manufacturing, life sciences, and clean energy. Our technologies, engineering competencies, and breadth of global services provide customers speed to market, high uptime, and rapid response, which equate to superior value in their mission-critical environments. Since 1978, Brooks has been a leading partner to the global semiconductor manufacturing market. Through product development initiatives and strategic acquisition, we have expanded our reach to meet the needs of customers in the life sciences industry, analytical and research fields, and clean energy markets. When optimal productivity and high availability are factors for success, customers across the globe turn to Brooks. Brooks is a public company listed on the NASDAQ stock exchange under the symbol BRKS

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by National Cancer Institute. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of National Cancer Institute's profile does not indicate a business or promotional relationship of any kind between RelSci and National Cancer Institute.